BU BÖLÜM HAKKINDA
Duplicate discount prevention is the process of ensuring a covered entity never claims both a 340B discount and a Medicaid rebate on the same drug unit. Vinson Tran, founder of Pharmacy Operation Solutions, explains why it's straightforward for retail pharmacy and genuinely hard for hospital mixed-use operations, and why he built his career around one rule: don't trust the system, trust the workflow you build to catch it when something's wrong.
In this episode, Vinson who holds a core TPA role at a hospital and founded Pharmacy Operation Solutions after watching an early 340B program get misused and shut down walks host Muhammad Atif through what actually prevents duplicate discounts in practice, why hospital mixed-use operations are a fundamentally harder problem than retail pharmacy, and how he manually isolates duplicate claims when hospital systems don't agree with each other.
He shares a concrete reimbursement example a $1,300 wholesale drug paid back at roughly $11 that makes the case for watching program revenue as closely as compliance, what to actually expect (and not expect) from TPA and split-billing software, and his honest, 50/50 take on HRSA's reproposed rebate model and the cash-flow risk it could create for small, thin-staffed covered entities.
What You'll Learn in This Episode
Why duplicate discount prevention requires at minimum two data sets, always The one file every hospital 340B program depends on, and why it's the most common point of failure How to build a temporary fix when hospital transaction IDs don't match across systems Why a $1,300 drug reimbursed at $11 isn't a compliance failure it's a revenue-visibility problem What to ask a TPA or software vendor before accepting any new feature Vinson's honest take on where AI helps in 340B today, and where it still falls short What actually happens during an HRSA audit, and how to prepare before one is ever announced
00:00 Introduction to 340B Pulse
00:33 Guest introduction: Vinson Tran
02:48 Vinson's journey into 340B
04:37 His experience with two HRSA audits
06:35 What duplicate discount prevention actually requires
11:09 Medicaid carve-in vs. carve-out decisions
13:10 The most common mistake covered entities make
14:24 Mixed-use hospital operations, explained
17:20 What hospitals should monitor regularly
19:25 Data, reporting, and review rooms
21:16 The KPIs that show whether a program is healthy
23:56 TPA software and vendor accountability
29:42 Questions to ask your TPA regularly
31:06 Where AI fits (and doesn't) in 340B
34:54 The reproposed HRSA rebate model
38:17 How to prepare for an HRSA audit
40:56 Rapid-fire round43:28 Final takeaway and closing
What is duplicate discount prevention in 340B?
Duplicate discount prevention is the process that ensures a covered entity never claims both a 340B discount and a Medicaid rebate on the same drug unit, verified by matching pharmacy claims data against 340B software data and confirming the correct Medicaid modifier.
Why is duplicate discount prevention harder for hospitals than retail pharmacies?
Because hospital claims pass through the EMR, IT, billing, inpatient, and outpatient systems before reaching the 340B splitter, while retail pharmacy owns the entire process end to end, making the hospital's charge file the critical point to monitor.
What should covered entities ask their TPA or software vendor regularly?
One core question before accepting any new feature or enhancement: how does this actually impact my covered entity?
#HealthSystemPharmacy#HealthcareLeadership#HealthTech#340BPulse#NorthArcHealth
